IPP Bureau
India’s first homegrown mRNA COVID-19 vaccine likely to have low market penetration, says GlobalData
By IPP Bureau - July 11, 2022
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
Glenmark Pharma launches Minym Gel for acne treatment
By IPP Bureau - July 11, 2022
MINYM can be safely used by patients above 9 years of age.
Piramal Pharma strengthens board by inducting three new board members
By IPP Bureau - July 11, 2022
The appointments will add to the well-diversified experience that currently exists on the PPL board.
MFine and LifeCell form JV ‘LifeWell’
By IPP Bureau - July 11, 2022
LifeWell Raises USD 80M from OrbiMed to Build Large Scale Healthcare Delivery Platform with Full stack Diagnostics~
.png "Feeling younger can help us rehabilitate faster : Study")
Feeling younger can help us rehabilitate faster : Study
By IPP Bureau - July 11, 2022
Researchers from Bar-Ilan University find that even in old age, feeling young can lower the risks of developing physical disability and morbidity
Govt introduces 'Draft of New Drugs, Medical Devices and Cosmetics Bill, 2022'
By IPP Bureau - July 11, 2022
The Bill aims to amend and consolidate the law relating to the import, manufacture, distribution and sale of drugs, medical devices and cosmetics
Themis Medicare’s VIRALEX effective against viral respiratory infections
By IPP Bureau - July 10, 2022
Themis Medicare’s VIRALEX is an effective and safe drug for management of mild to moderate COVID and other acute viral respiratory infections.
Sirio Pharma announces agreement to acquire best formulations
By IPP Bureau - July 10, 2022
The combined company will be able to better serve both our global and regional customers with local production
Dr. Reddy's Labs launches Fesoterodine Fumarate tablets in US
By IPP Bureau - July 10, 2022
Dr. Reddy's Fesoterodine Fumarate Extended-Release Tablets are available in 4 mg and 8 mg Tablets, each in bottle count sizes of 30.
Zydus launches Sitaglyn and Siglyn for the management of Type 2 diabetes
By IPP Bureau - July 10, 2022
The addition of Sitaglyn and Siglyn to our diabetes portfolio will give patients access to a world-class oral therapy to help people manage their diabetes
Mandaviya calls for collaboration to eliminate vector borne diseases
By IPP Bureau - July 10, 2022
China medical devices market to surpass $42 billion in 2022: GlobalData
By IPP Bureau - July 10, 2022
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
Capnopharm to acquire operational assets of Capnomed
By IPP Bureau - July 10, 2022
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
WuXi XDC and AbTis sign MoU for manufacturing of antibody drug conjugates
By IPP Bureau - July 10, 2022
AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing
ALPLA acquires Polish packaging manufacturer APON
By IPP Bureau - July 08, 2022
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
